Literature DB >> 11533702

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

S AbdAlla1, H Lother, A el Massiery, U Quitterer.   

Abstract

Several examples of functional G-protein-coupled receptor heterodimers have been identified. However, it is not known whether receptor heterodimerization is involved in the pathogenesis of human disorders. Here we show that in preeclamptic hypertensive women, a significant increase in heterodimerization occurs between the AT(1)-receptor for the vasopressor angiotensin II and the B(2)-receptor for the vasodepressor bradykinin. AT(1)-B(2)-receptor heterodimerization in preeclampsia correlated with a 4-5-fold increase in B(2)-receptor protein levels. Expression of the AT(1)-B(2) heterodimer increased the responsiveness to angiotensin II and conferred resistance in AT(1)-receptors to inactivation by reactive oxygen species raised in normotensive and preeclamptic pregnancies. We suggest that AT(1)-B(2) heterodimers contribute to angiotensin II hypersensitivity in preeclampsia. Moreover, we identify preeclampsia as the first disorder associated with altered G-protein-coupled receptor heterodimerization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533702     DOI: 10.1038/nm0901-1003

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  114 in total

Review 1.  Purinergic-receptor oligomerization: implications for neural functions in the central nervous system.

Authors:  Hiruyasu Nakata; Kazuaki Yoshioka; Toshio Kamiya
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells.

Authors:  Kevin D G Pfleger; Karin A Eidne
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

Review 5.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Targeting opioid receptor heterodimers: strategies for screening and drug development.

Authors:  Achla Gupta; Fabien M Décaillot; Lakshmi A Devi
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

Review 7.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

8.  Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.

Authors:  Mark W Cunningham; Jan M Williams; Lorena Amaral; Nathan Usry; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

9.  CRH-stimulation of cyclic adenosine 5'-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2alpha.

Authors:  G Maya-Núñez; C Castro-Fernández; J P Méndez
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

10.  Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Authors:  Liza Barki-Harrington; Angela L Bookout; Gaofeng Wang; Maria E Lamb; L M Fredrik Leeb-Lundberg; Yehia Daaka
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.